These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37193052)

  • 1. Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus.
    Xu Z; Liu X; Ma X; Zou W; Chen Q; Chen F; Deng X; Liang J; Dong C; Lan K; Wu S; Zhou HB
    Cell Insight; 2022 Jun; 1(3):100030. PubMed ID: 37193052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.
    Li L; Li Y; Zhang L; Hou T
    J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Boron-Containing
    Jia R; Zhang J; Zhang J; Bertagnin C; Bonomini A; Guizzo L; Gao Z; Ji X; Li Z; Liu C; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.
    Kiso M; Shinya K; Shimojima M; Takano R; Takahashi K; Katsura H; Kakugawa S; Le MT; Yamashita M; Furuta Y; Ozawa M; Kawaoka Y
    PLoS Pathog; 2010 Aug; 6(8):e1001079. PubMed ID: 20865125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards.
    Gillman A; Muradrasoli S; Söderström H; Holmberg F; Latorre-Margalef N; Tolf C; Waldenström J; Gunnarsson G; Olsen B; Järhult JD
    Appl Environ Microbiol; 2015 Apr; 81(7):2378-83. PubMed ID: 25616792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oseltamivir-resistant avian H1N1 influenza A virus can transmit from mallards to chickens similarly to a wild-type strain: implications for the risk of resistance transmission to humans.
    Skog E; Nykvist M; Naguib MM; Wille M; Bröjer C; Agarwal V; Ellström P; Westman G; Lundkvist Å; Järhult JD
    J Gen Virol; 2023 Apr; 104(4):. PubMed ID: 37018118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.
    Hanpaibool C; Leelawiwat M; Takahashi K; Rungrotmongkol T
    J Comput Aided Mol Des; 2020 Jan; 34(1):27-37. PubMed ID: 31773463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
    Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.
    Kannan S; Kolandaivel P
    J Biomol Struct Dyn; 2018 Dec; 36(16):4255-4269. PubMed ID: 29199545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Design of an Oseltamivir Derivative with Increased Affinity against Wild-Type and Mutant Variants of Neuraminidase and Hemagglutinin of Influenza A H1N1 Virus.
    Jazmin GM; Elaheh M; Manuel Jonathan FV; Martiniano B; David ML; Alám LC; José CB
    Chem Biodivers; 2023 Jul; 20(7):e202201077. PubMed ID: 37377353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.
    Hussain Basha S; Prasad RN
    BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
    Baz M; Abed Y; Simon P; Hamelin ME; Boivin G
    J Infect Dis; 2010 Mar; 201(5):740-5. PubMed ID: 20100088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase.
    Zhao H; Jiang S; Ye Z; Zhu H; Hu B; Meng P; Hu Y; Zhang H; Wang K; Wang J; Tian Y
    Eur J Med Chem; 2021 Oct; 221():113567. PubMed ID: 34082224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
    Gooskens J; Jonges M; Claas EC; Meijer A; van den Broek PJ; Kroes AM
    JAMA; 2009 Mar; 301(10):1042-6. PubMed ID: 19255111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.